Key Shareholder Information
An overview of the most recent information about MDxHealth can be found in the company’s periodic corporate presentation slides. The latest MDxHealth Corporate Presentation can be downloaded here.
Corporate Governance Charter
MDxHealth attaches great value to corporate governance practices. On September 7, 2011, our board of directors approved the current version of MDxHealth’s Corporate Governance Charter. The Charter has been drafted in accordance with the principles and the provisions of the Belgian Corporate Governance Code 2009 issued on March 12, 2009 by the Corporate Governance Committee.
The full text of MDxHealth’s Corporate Governance Charter can be downloaded here.
Code of Ethics
The full text of MDxHealth's Code of Ethics can be downloaded here.
As a listed company, MDxHealth must comply with rules governing insider trading. The company's dealing code can be found here.
Articles of Association
The Articles of Association are periodically updated. The latest version (June 20, 2016) can be found here:
Share capital history
The history of the share capital issuance since the inception of the company can be found here:
Transparency Declarations of the largest shareholders
The table below provides an overview of the shareholders that filed a notifcation with MDxHealth SA pursuant to applicable transparency disclosure rules. Although the applicable transparency disclosure rules require that a disclosure must be made by each person passing or falling under one of the relevant thresholds, it is possible that the information below in relation to a shareholder is no longer up-to-date. The percentages of voting rights mentioned in the table have been calculated on the basis of the currently outstanding shares.
|Shareholder (or Party representing shareholders)||VALIANCE ASSET MANAGEMENT||BIOVEST COMM.VA||TOTAL OF NOTIFIED SHARES||TOTAL OUTSTANDING SHARES|
|NUMBER OF SHARES||6,366,834||6,600,969||12,967,803||49,845,595|
|% OF OUTSTANDING SHARES||12.77 %||13.24 %||26.01 %||100%|
|SITUATION AS OF||NOV. 24, 2016||NOV. 24, 2016|
|NOTIFICATION RECEIVED||JULY 3, 2015||JULY 1, 2015|
|NOTIFICATION FORM||Click to view form||Click to view form|
Each natural or legal person acquiring or transferring MDxHealth’s shares is required to notify MDxHealth and the Financial Services and Markets Authority (FSMA) each time their shareholding crosses a threshold of three percent (3%) of the total number of outstanding shares (the denominator). Such notification is also required each time, as a result of an acquisition or transfer a threshold of five percent (5%) and a multiple of five percent (5%) is crossed. Complete information regarding this requirement is found in Article 14 of MDxHealth’s articles of association.
The transparency notifications should be reported within 5 business days of crossing the threshold by following the procedures outlined on the FSMA website found here.
A copy of the transparency notification should also be emailed and faxed to the company, to the attention of: Francis Ota, EVP of Finance, at email@example.com and fax +32 4 364 20 71.
Annual Shareholders' Meetings
The annual general shareholders’ meeting is held at the registered office or at the place determined in the notice convening the shareholders’ meeting. The meeting is held every year on the last Friday of May at 10 a.m. The notice and agenda, as well as a model of power of attorney are made available here at least 30 calendar days prior to the annual shareholders' meeting.
Next Extraordinary Shareholder's Meeting Material
Notice/invitation/agenda for the Annual Shareholders' meetings
Proxy form for the Annual Shareholders' meetings